EDGAR Filing Documents for 0001193125-22-058489

Form POS AM - Post-Effective amendments for registration statement:

SEC Accession No. 0001193125-22-058489

Filing Date

2022-03-01

Accepted

2022-02-28 17:46:20

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	POS AM	d323639dposam.htm	POS AM	381573
2	EX-5.1	d323639dex51.htm	EX-5.1	35689
3	EX-23.1	d323639dex231.htm	EX-23.1	1825
4	GRAPHIC	g323639g00r01.jpg	GRAPHIC	26370
5	GRAPHIC	g323639g94w35.jpg	GRAPHIC	2140
	Complete submission text file	0001193125-22-058489.txt		459708

Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080

Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412

SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-255014 | Film No.: 22692053
SIC: 2836 Biological Products, (No Diagnostic Substances)